Pulendran is investigating the interaction between the human immune system and the SARS-CoV-2 virus through systems-biological methods. His group will use a “multi-omics” approach to probe the host immune system response to SARS-CoV-2 during asymptomatic and symptomatic phases of infection. Their goal is to determine why some people get more severe symptoms than others and to identify biomarkers that predict disease severity in vulnerable populations. His group will also study the immune mechanisms by which vaccines confer protection against SARS-CoV-2. Stanford Office of Technology Licensing info@otlmail.stanford.edu. 650-723-0651
Smart, interactive desk
Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the